# Nuvig Therapeutics

**Canonical:** https://apis.io/providers/nuvig-therapeutics/  
**Website:** https://nuvigtx.com/  
**APIs profiled:** 0

Nuvig Therapeutics, Inc. is a privately held, clinical-stage biotechnology company headquartered at 3450 Hillview Avenue, Palo Alto, California, developing next-generation immunomodulators for chronic autoimmune and inflammatory disease. Its lead investigational candidate, NVG-2089, is an engineered Fc fragment designed to selectively engage type II Fc receptors and harness an endogenous regulatory mechanism that resolves autoimmune dysregulation while preserving normal immune function; the first patient was dosed in a Phase 2 trial in chronic inflammatory demyelinating polyneuropathy (CIDP) in May 2025. The company announced a $161 million Series B financing in December 2024. Nuvig is a therapeutics developer, not a software vendor: as of August 2026 it publishes no developer portal, API reference, SDK, GitHub organization, or machine-readable API contract of any kind. Its public web surface is a corporate WordPress site covering science, pipeline, team, news and careers, from which the only machine-readable artifact published is a Yoast-generated llms.txt.

## Kin Score — 11.5 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 11.5).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.2 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Nuvig Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Immunology, Autoimmune Disease, Therapeutics, Clinical Trials, Life Sciences, United States

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/nuvig-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.